Ted C. Nark - 06 May 2026 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Reporting relationship: Director
Issuer ticker: AMRX
Reported as of: 06 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 May 2026, 16:23:39 UTC
Prior SEC filing: 19 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Denis Butkovic, Attorney-in-Fact

Key filing fact

Ted C. Nark filed Form 4 for Amneal Pharmaceuticals, Inc. (AMRX) on 08 May 2026.

Key facts

This page summarizes Ted C. Nark's Form 4 filing for Amneal Pharmaceuticals, Inc. (AMRX).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 08 May 2026, 16:23.

Change

Previous filing in this sequence was filed on 19 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001316851 Primary reporting owner

Nark Ted C

Relationship: Director
Address: C/O AMNEAL PHARMACEUTICALS, INC., 400 CROSSING BOULEVARD, BRIDGEWATER
Signature: /s/ Denis Butkovic, Attorney-in-Fact
Signature date: 08 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMRX transaction

Class A Common Stock

Options Exercise

Transaction value
Shares: +34,819
Change %: +12%
Price
Shares after: 325,848
Date: 07 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMRX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -34,819
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 07 May 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 34,819
Exercise price
Footnotes: F1, F2

AMRX transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +19,824
Change %
Price: $0.000000^*
Shares after: 19,824
Date: 06 May 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 19,824
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Footnote F2

On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026.

Footnote F3

Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.